Applied Therapeutics, Inc. — Director's Dealing 2019

May 14, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2019-05-13

Reporting Person: ALEXANDRIA REAL ESTATE EQUITIES INC (10% Owner)
Reporting Person: Alexandria Venture Investments, LLC (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Preferred Stock	$		Common Stock (800716.0)		Indirect
Series B Preferred Stock	$		Common Stock (1614860.0)		Indirect

Footnotes

F1: The preferred stock is convertible into the Issuer's common stock at a ratio of 1 share of preferred stock to 1 share of common stock at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering, for no additional consideration.

F2: Not applicable

F3: These shares are held directly by Alexandria Venture Investments, LLC, a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. Of these shares, 1,243,977 shares of Series B Preferred Stock are held by Alexandria Venture Investments, LLC as nominee for Alexandria Equities No. 7, LLC, another wholly owned subsidiary of Alexandria Real Estate Equities, Inc.